MALVERN, Pa. & MONTREAL--(BUSINESS WIRE)--Gemin X Pharmaceuticals, Inc., a privately held pharmaceutical company focused on developing novel treatments for cancer, announced the appointment of Peter R. Dolan to its Board of Directors.
MALVERN, Pa. & MONTREAL--(BUSINESS WIRE)--Gemin X Pharmaceuticals, Inc., a privately held pharmaceutical company focused on developing novel treatments for cancer, announced the appointment of Peter R. Dolan to its Board of Directors.
